Report Store
Global Cell and Gene Therapy Market (Types, Therapeutic Class, Marketed Products, World Regions) & Forecast to 2028
Date: Mar, 2021 / Pages: 230 / Category: Healthcare
| Report Format | Price | Action | |
|---|---|---|---|
| Electronic Access - Single User License (PDF) | $1,350 | BUY | Your Query |
| Single User (PDF) + CD ROM Delivery | $1,400 | BUY | Your Query |
| Single Site - Multi Users License (PDF) | $1,600 | BUY | Your Query |
| Global Site - Multi Users License (PDF) | $1,750 | BUY | Your Query |
Cell and gene therapies are the leading innovation to treat severe diseases such as cancer, as well as rare diseases. At present several therapies are in the market globally such as Yescarta, Kymriah, Alofisel, MACI, Epicel, Zolgensma, Luxturna etc. Many other cell and gene therapy are also in the developing phase. As of June 2020, more than 750 trials of cell and gene therapies in almost 30,000 patients were underway. COVID-19 has caused significant disruption to the cell and gene therapy industry because of the complex manufacturing, delivery and funding model. Cell collection, supply shortages and administration of cell and gene therapies have also proved problematic during the COVID-19 pandemic. Research programs and preclinical activities have been affected as companies have to reduce the number of people working on-site to keep them safe and follow the government's advice.
MNG Tracker anticipated that numbers of clinical trials and regulatory approvals for cell and gene therapies are expected to rise over the years to come. The US FDA anticipates that by 2025 it will approve 10 to 20 cell and gene therapy products per year. It is expected that the global cell and gene therapy market will grow at a CAGR of over 23 percent during the forecasting year 2021-2028 and likely to cross US$ 21 Billion landmarks in 2028. Cell therapy is dominating the global cell and gene therapy market. In the context of therapeutic class, Rare Diseases and oncology hold the majority of the share in this marketplace. However, Yescarta and Kymriah will hold the majority of the market share in the global cell and gene therapy market.
MNG Tracker report titled "Global Cell and Gene Therapy Market by Type (Cell, Gene), by Therapeutic Class (Rare Diseases, Oncology, Hematology, Cardiovascular, Ophthalmology, Neurology, Other), by Products (Yescarta, Kymriah, Alofisel, MACI, Epicel, Zolgensma, Invossa, Luxturna, Zynteglo, Others), by Regions (North America, Europe, Asia-Pacific, Latin America, Other), by Company (Novartis, Gilead Sciences, Bristol-Myers Squibb, JW Therapeutics, 4basebio AG, CRISPR Therapeutics)” provides an all-encompassing insight of cell and gene therapy industry.
The objective of this study is to analyze Global Cell and Gene Therapy market by two prospective - cell and gene therapy market and biopharmaceutical company’s initiatives. Under the market section, we identifying the market growth potentials and market value by types, therapeutic class, marketed products and regions, growth drivers, challenges; whereas in company section our objectives are: to find out the key companies latest initiatives, company clinical trials and sales revenue in this market place.
This 230 pages study report with 65 Figures & 1 Tables studies the Global Cell and Gene Therapy market from 8 view points:
- Market and Forecast
- Market Share and Forecast
- By Types - Market & Forecast
- By Therapeutic Class - Market & Forecast
- By Products – Market & Forecast
- By Regions - Market & Forecast
- Cell and Gene Therapy - Growth Drivers & Challenges
- Cell and Gene Therapy - Company Profiles (Company overview, latest initiatives, clinical trials, sales revenue)
Global Cell and Gene Therapy Market - By Types
- Cell Therapy
- Gene Therapy
Global Cell and Gene Therapy Market - By Therapeutic Class
- Rare Diseases
- Oncology
- Hematology
- Cardiovascular
- Ophthalmology
- Neurology
- Other
Global Cell and Gene Therapy Market - By Marketed Products
- Yescarta
- Kymriah
- Alofisel
- MACI
- Epicel
- Zolgensma
- Invossa
- Luxturna
- Zynteglo
- Others
Global Cell and Gene Therapy Market - By Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Rest of the World
Key Company Profile - Company overview, latest initiatives, clinical trials, sales revenue
- Novartis
- Gilead Sciences (Kite Pharma)
- Bristol-Myers Squibb (Celgene)
- JW Therapeutics
- 4basebio AG
- CRISPR Therapeutics
1 Market Definition
2 Research and Methodology
3 Executive Summary
4 Cell and Gene Therapy - Market Overview
5 Global Cell and Gene Therapy Market & Forecast (2018 – 2028)
6 Global Cell and Gene Therapy Market Share & Forecast (2018 - 2028)
6.1 By Therapy Type
6.2 By Therapeutic Class
6.3 By Products
6.4 By Regions
7 By Therapy Type - Global Cell and Gene Therapy Market (2018 -2028)
7.1 Cell Therapy
7.2 Gene Therapy
8 By Therapeutic Applications - Global Cell and Gene Therapy Market (2018 -2028)
8.1 Rare Diseases
8.2 Oncology
8.3 Hematology
8.4 Cardiovascular
8.5 Ophthalmology
8.6 Neurology
8.7 Other
9 By Products - Global Cell and Gene Therapy Market (2018 -2028)
9.1 Yescarta
9.1.1 Mechanism of Action
9.1.2 Dosing and Administration
9.1.3 Yescarta Cost in Approved Countries
9.1.4 Yescarta Global Sales (2018 - 2028)
9.2 Kymriah
9.2.1 Mechanism of Action
9.2.2 Dosing and Administration
9.2.3 Yescarta Cost in Approved Countries
9.2.4 Yescarta Global Sales (2018 - 2028)
9.3 Alofisel
9.3.1 Mechanism of Action
9.3.2 Dosing and Administration
9.3.3 Alofisel Cost in Approved Countries
9.3.4 Alofisel Global Sales (2018 - 2028)
9.4 MACI
9.4.1 Mechanism of Action
9.4.2 Dosing and Administration
9.4.3 Regulatory Approval
9.4.4 MACI Global Sales (2018 - 2028)
9.5 Epicel
9.5.1 Mechanism of Action
9.5.2 Regulatory Approval
9.5.3 Epicel Global Sales (2018 - 2028)
9.6 Zolgensma
9.6.1 Mechanism of Action
9.6.2 Dosing and Administration
9.6.3 Zolgensma Cost in Approved Countries
9.6.4 Zolgensma Global Sales (2018 - 2028)
9.7 Invossa Global Sales (2022 - 2028)
9.8 Luxturna
9.8.1 Mechanism of Action
9.8.2 Dosing and Administration
9.8.3 Luxturna Cost in Approved Countries
9.8.4 Luxturna Global Sales (2020 - 2028)
9.9 Zynteglo
9.9.1 Mechanism of Action
9.9.2 Dosing and Administration
9.9.3 Zynteglo Cost in Approved Countries
9.9.4 Zynteglo Global Sales (2022 - 2028)
9.10 Others
10 By World Regions - Global Cell and Gene Therapy Market (2018 -2028)
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Latin America
10.5 Rest of World (ROW)
11 Growth Drivers - Global Cell and Gene Therapy Market
11.1 Cell and Gene Therapy Deals are Growing Rapidly
11.2 Technological Advancement
11.3 Favorable Regulatory Developments
11.4 Growing Demand for CAR-T Cell Therapy Products
12 Challenges - Global Cell and Gene Therapy Market
12.1 Logistic Challenges in Cell and Gene Therapy
12.2 Limited Number of Certified Academic Medical Centers
12.3 Current Reimbursement for CGTS is Insufficient
13 Company Profiles - Global Cell and Gene Therapy Market
13.1 Novartis
13.1.1 Company Overview
13.1.2 Company Initiatives/News
13.1.3 Company Cell and Gene Therapy Revenue (2018 -2028)
13.2 Gilead Sciences (Kite Pharma)
13.2.1 Company Overview
13.2.2 Company Initiatives/News
13.2.3 Company Cell and Gene Therapy Clinical Trials
13.2.4 Company Cell and Gene Therapy Revenue (2018 -2028)
13.3 Bristol-Myers Squibb (Celgene)
13.3.1 Company Overview
13.3.2 Company Initiatives/News
13.3.3 Company Global Revenue (2018 - 2028)
13.4 JW Therapeutics
13.4.1 Company Overview
13.4.2 Company Initiatives/News
13.4.3 Product Candidate
17.5 4basebio AG
13.5.1 Company Overview
13.5.2 Company Initiatives/News
13.5.3 Company Global Revenue (2018 - 2028)
17.6 CRISPR Therapeutics
13.6.1 Company Overview
13.6.2 Company Initiatives/News
13.6.3 Company Global Revenue (2023 - 2028)
Figure-1 Global – Cell and Gene Therapy Market (Million US$), 2018 - 2020
Figure-2 Forecast for Cell and Gene Therapy Market (Million US$), 2021 - 2028
Figure-3 Global - Therapy Type Market Share (Percent), 2018 - 2020
Figure-4 Forecast for Therapy Type Market Share (Percent), 2021 - 2028
Figure-5 Global Cell and Gene Therapy - Therapeutic Class Market Share (Percent), 2018 - 2020
Figure-6 Global Cell and Gene Therapy – Forecast for Therapeutic Class Market Share (Percent), 2021 - 2028
Figure-7 Global Cell and Gene Therapy – Products Market Share (Percent), 2018 - 2020
Figure-8 Global Cell and Gene Therapy – Forecast for Products Market Share (Percent), 2021 - 2028
Figure-9 Global Cell and Gene Therapy – Regions Market Share (Percent), 2018 - 2020
Figure-10 Global Cell and Gene Therapy – Forecast for Regions Market Share (Percent), 2021 - 2028
Figure-11 Global - Cell Therapy Market (Million US$), 2018 - 2020
Figure-12 Global - Forecast for Cell Therapy Market (Million US$), 2021 - 2028
Figure-13 Global - Gene Therapy Market (Million US$), 2018 - 2020
Figure-14 Global - Forecast for Gene Therapy Market (Million US$), 2021 - 2028
Figure-15 Global - Rare Diseases Cell & Gene Therapy Market (Million US$), 2018 - 2020
Figure-16 Global - Forecast for Rare Diseases Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-17 Global - Oncology Cell & Gene Therapy Market (Million US$), 2018 - 2020
Figure-18 Global - Forecast for Oncology Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-19 Global - Hematology Cell & Gene Therapy Market (Million US$), 2018 - 2020
Figure-20 Global - Forecast for Hematology Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-21 Global - Cardiovascular Cell & Gene Therapy Market (Million US$), 2018 - 2020
Figure-22 Global - Forecast for Cardiovascular Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-23 Global - Ophthalmology Cell & Gene Therapy Market (Million US$), 2018 - 2020
Figure-24 Global - Forecast for Ophthalmology Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-25 Global - Neurology Cell & Gene Therapy Market (Million US$), 2018 - 2020
Figure-26 Global - Forecast for Neurology Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-27 Global - Others Cell & Gene Therapy Market (Million US$), 2018 - 2020
Figure-28 Global - Forecast for Others Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-29 Global - Yescarta Market (Million US$), 2018 - 2020
Figure-30 Global - Forecast for Yescarta Market (Million US$), 2021 - 2028
Figure-31 Global - Kymriah Market (Million US$), 2018 - 2020
Figure-32 Global - Forecast for Kymriah Market (Million US$), 2021 - 2028
Figure-33 Global - Alofisel Market (Million US$), 2018 - 2020
Figure-34 Global - Forecast for Alofisel Market (Million US$), 2021 - 2028
Figure-35 Global - MACI Market (Million US$), 2016 - 2020
Figure-36 Global - Forecast for MACI Market (Million US$), 2021 - 2028
Figure-37 Global - Epicel Market (Million US$), 2016 - 2020
Figure-38 Global - Forecast for Epicel Market (Million US$), 2021 - 2028
Figure-39 Global - Zolgensma Market (Million US$), 2019 - 2020
Figure-40 Global - Forecast for Zolgensma Market (Million US$), 2021 - 2028
Figure-41 Global - Forecast for Invossa Market (Million US$), 2022 - 2028
Figure-42 Global - Present & Forecast for Luxturna Market (Million US$), 2020 - 2028
Figure-43 Global - Forecast for Zynteglo Market (Million US$), 2022 - 2028
Figure-44 Global - Others Market (Million US$), 2019 - 2020
Figure-45 Global - Forecast for Others Market (Million US$), 2021 - 2028
Figure-46 North America - Cell & Gene Therapy Market (Million US$), 2018 - 2020
Figure-47 North America - Forecast for Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-48 Europe - Cell & Gene Therapy Market (Million US$), 2018 - 2020
Figure-49 Europe - Forecast for Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-50 Asia Pacific - Cell & Gene Therapy Market (Million US$), 2018 - 2020
Figure-51 Asia Pacific - Forecast for Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-52 Latin America - Cell & Gene Therapy Market (Million US$), 2019 - 2020
Figure-53 Latin America - Forecast for Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-54 Other Countries - Cell & Gene Therapy Market (Million US$), 2019 - 2020
Figure-55 Other Countries - Forecast for Cell & Gene Therapy Market (Million US$), 2021 - 2028
Figure-56 Global Cell and Gene Therapy - M& A (Number of Deals, Deals Value), 2015 - 2019
Figure-57 Novartis – Cell and Gene Therapy Revenue, (2018 -2020)
Figure-58 Novartis – Forecast for Cell and Gene Therapy Revenue, (2021 -2028)
Figure-59 Gilead Sciences - Cell and Gene Therapy Revenue (Million US$), 2018 -2020
Figure-60 Gilead Sciences – Forecast for Cell and Gene Therapy Revenue (Million US$), 2021-2028
Figure-61 Bristol Myers Squibb (BMS) – Global Revenue (Million US$), 2018 - 2020
Figure-62 Bristol Myers Squibb (BMS) – Forecast for Global Revenue (Million US$), 2021 - 2028
Figure-63 4basebio - Global Revenue (Million US$), 2018 - 2020
Figure-64 4basebio – Forecast for Global Revenue (Million US$), 2021 - 2028
Figure-65 CRISPR Therapeutics – Forecast for Global Revenue (Million US$), 2023 - 2028
Table-1 Key Features - Global Cell and Gen Therapy Market
Thank you for showing interest in our Research Report - Global Cell and Gene Therapy Market (Types, Therapeutic Class, Marketed Products, World Regions) & Forecast to 2028
Please fill up the form and specify your research requirement.
Latest Reorts
MNG Tracker is a market research company which offer market research reports and database subscription service. Continuous tracking on latest changes in the industry and predict about the emerging needs, challenges and opportunities, is the essential needs for the growth of the business. MNG Tracker is exists for that. MNG Tracker is steadily monitored on the latest happening in the industries, companies and regulatory policies around the world. MNG Tracker is all about market, research and data. We know our clients; who they are, what they see and what they do. MNG Tracker team is fully dedicated to achieve their needs and expectation.
Useful Links
Contact Us
125/5D, Sector 5 Vrindavan Yojna,
Lucknow - 226002, India
Phone:+91 8527886312,
+ 91 7530849871
Email: info@mngtracker.com
FOLLOW USCOPYRIGHT © 2018 MNG Tracker. All Rights Reserved.
Confirm All Clear!
Do You Realy want to delete all items from you CART?